Therapeutic Trial of Fluoroscopic Interlaminar Epidural Steroid Injection for Axial Low Back Pain: Effectiveness and Outcome Predictors

References

1. 1.↵
   1. Manchikanti L

   . Medicare in interventional pain management: a critical analysis. Pain Physician 2006;9:171–97

   PubMed
2. 2.↵
   1. Manchikanti L,
   2. Cash KA,
   3. McManus CD,
   4. et al

   . Preliminary results of a randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain. Part 1. Discogenic pain without disc herniation or radiculitis. Pain Physician 2008;11:713–16

   PubMed
3. 3.↵
   1. Friedly J,
   2. Chan L,
   3. Deyo R

   . Increases in lumbosacral injections in the Medicare population: 1994 to 2001. Spine (Phila Pa 1976) 2007;32:1754–60

   CrossRef
4. 4.↵
   1. Buttermann GR

   . The effect of spinal steroid injections for degenerative disc disease. Spine J 2004;4:495–505

   CrossRefPubMed
5. 5.↵
   1. Manchikanti L,
   2. Singh V,
   3. Rivera JJ,
   4. et al

   . Effectiveness of caudal epidural injections in discogram positive and negative chronic low back pain. Pain Physician 2002;5:18–29

   PubMed
6. 6.↵
   1. Manchikanti L,
   2. Pampati V,
   3. Rivera JJ,
   4. et al

   . Caudal epidural injections with sarapin or steroids in chronic low back pain. Pain Physician 2001;4:322–35

   PubMed
7. 7.↵
   1. Parr AT,
   2. Diwan S,
   3. Abdi S

   . Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: a systematic review. Pain Physician 2009;12:163–88

   PubMed
8. 8.↵
   1. Khot A,
   2. Bowditch M,
   3. Powell J,
   4. et al

   . The use of intradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial. Spine (Phila Pa 1976) 2004;29:833–36, discussion 837
9. 9.↵
   1. Hyodo H,
   2. Sato T,
   3. Sasaki H,
   4. et al

   . Discogenic pain in acute nonspecific low-back pain. Eur Spine J 2005;14:573–77

   CrossRefPubMedWeb of Science
10. 10.↵
    1. McCarron RF,
    2. Wimpee MW,
    3. Hudkins PG,
    4. et al

    . The inflammatory effect of nucleus pulposus: a possible element in the pathogenesis of low-back pain. Spine (Phila Pa 1976) 1987;12:760–64
11. 11.↵
    1. Kang JD,
    2. Georgescu HI,
    3. McIntyre-Larkin L,
    4. et al

    . Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) 1996;21:271–77
12. 12.↵
    1. Matsui Y,
    2. Maeda M,
    3. Nakagami W,
    4. et al

    . The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation. Spine (Phila Pa 1976) 1998;23:863–68, discussion 868–6
13. 13.↵
    1. Virri J,
    2. Gronblad M,
    3. Seitsalo S,
    4. et al

    . Comparison of the prevalence of inflammatory cells in subtypes of disc herniations and associations with straight leg raising. Spine (Phila Pa 1976) 2001;26:2311–15
14. 14.↵
    1. Fardon DF,
    2. Milette PC

    . Nomenclature and classification of lumbar disc pathology: recommendations of the combined task forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine (Phila Pa 1976) 2001;26:E93–113

    CrossRef
15. 15.↵
    1. Aprill C,
    2. Bogduk N

    . High-intensity zone: a diagnostic sign of painful lumbar disc on magnetic resonance imaging. Br J Radiol 1992;65:361–69

    Abstract/FREE Full Text
16. 16.↵
    1. Modic MT,
    2. Steinberg PM,
    3. Ross JS,
    4. et al

    . Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology 1988;166:193–99

    PubMedWeb of Science
17. 17.↵
    1. Barre L,
    2. Lutz GE,
    3. Southern D,
    4. et al

    . Fluoroscopically guided caudal epidural steroid injections for lumbar spinal stenosis: a retrospective evaluation of long-term efficacy. Pain Physician 2004;7:187–93

    PubMed
18. 18.↵
    1. Manchikanti L,
    2. Singh V,
    3. Pampati V,
    4. et al

    . Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician 2001;4:308–16

    PubMed
19. 19.↵
    1. Flower RJ,
    2. Blackwell GJ

    . Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979;278:456–59

    CrossRefPubMed
20. 20.↵
    1. Manchikanti L

    . Role of neuraxial steroids in interventional pain management. Pain Physician 2002;5:182–99

    PubMed
21. 21.↵
    1. Wolfer LR,
    2. Derby R,
    3. Lee JE,
    4. et al

    . Systematic review of lumbar provocation discography in asymptomatic subjects with a meta-analysis of false-positive rates. Pain Physician 2008;11:513–38

    PubMed
22. 22.↵
    1. Carragee EJ,
    2. Lincoln T,
    3. Parmar VS,
    4. et al

    . A gold standard evaluation of the “discogenic pain” diagnosis as determined by provocative discography. Spine (Phila Pa 1976) 2006;31:2115–23
23. 23.↵
    1. Manchikanti L,
    2. Glaser SE,
    3. Wolfer L,
    4. et al

    . Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician 2009;12:541–59

    PubMed
24. 24.↵
    1. Carragee EJ,
    2. Alamin TF,
    3. Carragee JM

    . Low-pressure positive discography in subjects asymptomatic of significant low back pain illness. Spine (Phila Pa 1976) 2006;31:505–09
25. 25.↵
    1. Boswell MV,
    2. Trescot AM,
    3. Datta S,
    4. et al

    . Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 2007;10:7–111

    PubMed